A 2,700person realworld study presented at the 2025 European Congress on Obesity showed an average 16% weightloss over 64 weeks at microdose levels of semaglutide
Hims and Hers : Best for Wegovy Hims & Hers is a national telehealth provider now offering Wegovy through a direct partnership with Novo Nordisk, giving patients easier access to FDA-approved GLP-1 treatment without insurance
95% Cl, 0.5930.876), composite cardiovascular events (at years 7, HR, 0.594
What to expect: Noticeable decrease in appetite and cravings Smaller portions feel more satisfying Average weight loss: 510 pounds Blood sugar levels may already improve if you have diabetes Achieve tip: Side effects like nausea or constipation are common early on
PLoS One 2011;6:e25269.ArticlePubMedPMC 66
Despite the absence of adverse cardiovascular effects has been confirmed, this benefit was not verified in an integrated analysis of 12 controlled, randomized, short-term clinical trials (12-52 weeks) comparing exenatide with placebo or insulin [72]
